Maxifed
Product Images NDC 58605-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Maxifed (NDC 58605-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mcr American Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (360 mg/60 mg Tablet Bottle Label)

Principal Display Panel (360 mg/60 mg Tablet Bottle Label)
This is a drug label for a medicine that treats the common cold, allergies, or other respiratory allergies. The drug is an expectorant and nasal decongestant with active ingredients Guaifenesin and Pseudoephedrine. The medicine helps to loosen phlegm and reduce nasal congestion, itching, and watery eyes. There are warnings about not exceeding the recommended dosage, contacting a doctor if a cough persists for over a week, avoiding the drug if taking MAO inhibitors, and asking for a doctor's consultation before use if suffering from other health issues. The label includes directions for use, dosage, and storage, as well as the manufacturer's name and contact details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.